The Delhi High Court on Tuesday refused to grant Novo Nordisk an interim injunction against Dr. Reddy's Laboratories Ltd. and ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

India has the second-highest number of people with type 2 diabetes after China and rising obesity rates, making it a critical battleground for drugmakers ...

After Novo Nordisk sought an injunction alleging patent infringement, the Court found Dr. Reddy’s challenge to the patent ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Two large trials of Novo Nordisk's semaglutide showed no cognitive benefits for early Alzheimer's patients, dashing hopes for the drug as a potential treatment.

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

The blockbuster drug, marketed globally by Novo Nordisk as Ozempic for Type 2 diabetes and for obesity, has been at the ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

Advocates for European drugmakers say other countries must follow the UK to the bargaining table to stave off tariffs and ...

Scholar Rock Holding Corporation ( SRRK) Citi Annual Global Healthcare Conference 2025 December 3, 2025 1:00 PM EST ...